Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Abelcet trial results in children favorable

April 19, 1996

Cefdinir close to filing in U.S.

April 19, 1996

New patent issued to Interferon Sciences

April 12, 1996

Anti-HSV compound karalicin

April 12, 1996

Dutch approval for Amphocil

April 12, 1996

S-28679, a new interferon biosynthesis inducer from 3M

April 12, 1996

AmBisome approved for marketing in Spain

April 12, 1996

Mentax approvable for athlete's foot

April 12, 1996

New antifungals isolated from actinomycetes at Schering-Plough

April 12, 1996

L-742728 selected by Merck & Co. for further evaluation

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Circulating sncRNA transcriptome in diabetic kidney disease and SGLT2 inhibitor treatment
BioWorld Science
Small noncoding RNAs (sncRNAs), including miRNAs, piRNAs and snoRNAs, can provide further biological insights into the mechanisms of chronic kidney disease (CKD)...